Cargando…
Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo
The oral anti-diabetic drug metformin has been found to reduce cardiovascular complications independent of glycemic control in diabetic patients. However, its role in diabetic retinal microvascular complications is not clear. This study is to investigate the effects of metformin on retinal vascular...
Autores principales: | Han, Jing, Li, Yue, Liu, Xiuli, Zhou, Tongrong, Sun, Haijing, Edwards, Paul, Gao, Hua, Yu, Fu-Shin, Qiao, Xiaoxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841739/ https://www.ncbi.nlm.nih.gov/pubmed/29513760 http://dx.doi.org/10.1371/journal.pone.0193031 |
Ejemplares similares
-
Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium
por: Li, Yue, et al.
Publicado: (2022) -
Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients
por: Li, Yue, et al.
Publicado: (2018) -
Metformin: The next angiogenesis panacea?
por: Ren, Yu, et al.
Publicado: (2021) -
Ethanol extract of Gleditsia sinensis thorn suppresses angiogenesis in vitro and in vivo
por: Yi, Jin-Mu, et al.
Publicado: (2012) -
Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo
por: Wang, Gang, et al.
Publicado: (2022)